| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3646800
[patent_doc_number] => 05605689
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-25
[patent_title] => 'Treatment of HIV-associated immune thrombocytopenic purpura'
[patent_app_type] => 1
[patent_app_number] => 8/237962
[patent_app_country] => US
[patent_app_date] => 1994-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6496
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/605/05605689.pdf
[firstpage_image] =>[orig_patent_app_number] => 237962
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/237962 | Treatment of HIV-associated immune thrombocytopenic purpura | May 2, 1994 | Issued |
Array
(
[id] => 3831586
[patent_doc_number] => 05846534
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-08
[patent_title] => 'Antibodies to the antigen campath-1'
[patent_app_type] => 1
[patent_app_number] => 8/235705
[patent_app_country] => US
[patent_app_date] => 1994-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 21
[patent_no_of_words] => 9087
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/846/05846534.pdf
[firstpage_image] =>[orig_patent_app_number] => 235705
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/235705 | Antibodies to the antigen campath-1 | Apr 28, 1994 | Issued |
| 08/235406 | NOVEL VZV GENE, MUTANT VZV AND IMMUNOGENIC COMPOSITIONS | Apr 27, 1994 | Abandoned |
| 08/233619 | SYNTHETIC HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS | Apr 25, 1994 | Abandoned |
Array
(
[id] => 3555455
[patent_doc_number] => 05519117
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-21
[patent_title] => 'Isolated, tyrosinase derived peptides and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/233305
[patent_app_country] => US
[patent_app_date] => 1994-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 32
[patent_no_of_words] => 7289
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/519/05519117.pdf
[firstpage_image] =>[orig_patent_app_number] => 233305
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/233305 | Isolated, tyrosinase derived peptides and uses thereof | Apr 25, 1994 | Issued |
| 08/226388 | BISPECIFIC HETEROANTIBODIES WITH DUAL EFFECTOR FUNCTIONS | Apr 11, 1994 | Abandoned |
Array
(
[id] => 3704364
[patent_doc_number] => 05674984
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-07
[patent_title] => 'Method for isolation of unclipped HIV envelope protein'
[patent_app_type] => 1
[patent_app_number] => 8/226162
[patent_app_country] => US
[patent_app_date] => 1994-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 23821
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/674/05674984.pdf
[firstpage_image] =>[orig_patent_app_number] => 226162
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/226162 | Method for isolation of unclipped HIV envelope protein | Apr 10, 1994 | Issued |
Array
(
[id] => 3411523
[patent_doc_number] => 05443957
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-08-22
[patent_title] => 'Anti-asialo-GM1 monoclonal antibodies and method of use'
[patent_app_type] => 1
[patent_app_number] => 8/225075
[patent_app_country] => US
[patent_app_date] => 1994-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4403
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/443/05443957.pdf
[firstpage_image] =>[orig_patent_app_number] => 225075
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/225075 | Anti-asialo-GM1 monoclonal antibodies and method of use | Apr 7, 1994 | Issued |
| 08/137183 | CATIONIZED ANTIBODIES AGAINST INTRACELLULAR PROTEINS | Mar 20, 1994 | Abandoned |
Array
(
[id] => 4307365
[patent_doc_number] => 06241986
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Human monoclonal antibodies to the CD4-binding domain of HIV, uses thereof and synergistic neutralization of HIV'
[patent_app_type] => 1
[patent_app_number] => 8/215395
[patent_app_country] => US
[patent_app_date] => 1994-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 11044
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/241/06241986.pdf
[firstpage_image] =>[orig_patent_app_number] => 215395
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/215395 | Human monoclonal antibodies to the CD4-binding domain of HIV, uses thereof and synergistic neutralization of HIV | Mar 20, 1994 | Issued |
| 08/214837 | SYNERGISTIC INHIBITION OF HIV-1 INFECTION USING A NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR AND ANTI-HIV-1 ANTIBODIES | Mar 15, 1994 | Abandoned |
| 08/213743 | METHODS TO DIAGNOSE AND TREAT HIV-1 INFECTION | Mar 13, 1994 | Abandoned |
| 08/202572 | ANTIGEN-BASED HETEROPOLYMERS AND METHOD FOR TREATING AUTOIMMUNE DISEASES USING THE SAME | Feb 27, 1994 | Abandoned |
Array
(
[id] => 3521267
[patent_doc_number] => 05530096
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-25
[patent_title] => 'Isolated, tyrosinase derived peptides and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/203054
[patent_app_country] => US
[patent_app_date] => 1994-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 30
[patent_no_of_words] => 6905
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/530/05530096.pdf
[firstpage_image] =>[orig_patent_app_number] => 203054
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/203054 | Isolated, tyrosinase derived peptides and uses thereof | Feb 27, 1994 | Issued |
Array
(
[id] => 3666704
[patent_doc_number] => 05597896
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-28
[patent_title] => 'Retrovirus human immunodeficiency virus type 2(HIV2), capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes'
[patent_app_type] => 1
[patent_app_number] => 8/202260
[patent_app_country] => US
[patent_app_date] => 1994-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5012
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/597/05597896.pdf
[firstpage_image] =>[orig_patent_app_number] => 202260
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/202260 | Retrovirus human immunodeficiency virus type 2(HIV2), capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes | Feb 24, 1994 | Issued |
Array
(
[id] => 3590683
[patent_doc_number] => 05487890
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-01-30
[patent_title] => 'Mammalian primate erythrocyte bound heteropolymerized monoclonal antibodies and methods of use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/186136
[patent_app_country] => US
[patent_app_date] => 1994-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4102
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/487/05487890.pdf
[firstpage_image] =>[orig_patent_app_number] => 186136
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/186136 | Mammalian primate erythrocyte bound heteropolymerized monoclonal antibodies and methods of use thereof | Jan 23, 1994 | Issued |
| 08/178302 | HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS | Jan 5, 1994 | Abandoned |
| 08/165314 | OLIGOMERIC HIV-1 ENVELOPE GLYCOPROTEINS | Dec 9, 1993 | Abandoned |
Array
(
[id] => 3485779
[patent_doc_number] => 05470570
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-28
[patent_title] => 'Mammalian primate erythrocyte bound heteropolymerized monoclonal antibodies and methods of use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/161812
[patent_app_country] => US
[patent_app_date] => 1993-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4080
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/470/05470570.pdf
[firstpage_image] =>[orig_patent_app_number] => 161812
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/161812 | Mammalian primate erythrocyte bound heteropolymerized monoclonal antibodies and methods of use thereof | Dec 5, 1993 | Issued |
| 08/148609 | PRODUCTION OF PROTEINS BY CELL CULTURE | Nov 7, 1993 | Abandoned |
